0001209191-17-030211.txt : 20170505
0001209191-17-030211.hdr.sgml : 20170505
20170505122508
ACCESSION NUMBER: 0001209191-17-030211
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20170427
FILED AS OF DATE: 20170505
DATE AS OF CHANGE: 20170505
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CymaBay Therapeutics, Inc.
CENTRAL INDEX KEY: 0001042074
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943103561
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7999 GATEWAY BLVD
STREET 2: SUITE 130
CITY: NEWARK
STATE: CA
ZIP: 94560
BUSINESS PHONE: 510-293-8800
MAIL ADDRESS:
STREET 1: 7999 GATEWAY BLVD
STREET 2: SUITE 130
CITY: NEWARK
STATE: CA
ZIP: 94560
FORMER COMPANY:
FORMER CONFORMED NAME: METABOLEX, INC.
DATE OF NAME CHANGE: 20090721
FORMER COMPANY:
FORMER CONFORMED NAME: METABOLEX INC
DATE OF NAME CHANGE: 19970710
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Menold Daniel
CENTRAL INDEX KEY: 0001705745
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36500
FILM NUMBER: 17817163
MAIL ADDRESS:
STREET 1: C/O CYMABAY THERAPEUTICS, INC.
STREET 2: 7999 GATEWAY BLVD., SUITE 130
CITY: NEWARK
STATE: CA
ZIP: 94560
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2017-04-27
0
0001042074
CymaBay Therapeutics, Inc.
CBAY
0001705745
Menold Daniel
C/O CYMABAY THERAPEUTICS, INC.
7999 GATEWAY BLVD., SUITE 130
NEWARK
CA
94560
0
1
0
0
Vice President, Finance
Stock Option (right to buy)
5.00
2024-01-21
Common Stock
19459
D
Stock Option (right to buy)
10.00
2025-01-06
Common Stock
7000
D
Stock Option (right to buy)
1.06
2026-01-25
Common Stock
8500
D
Stock Option (right to buy)
1.82
2026-07-24
Common Stock
1545
D
Stock Option (right to buy)
1.72
2027-01-18
Common Stock
15000
D
Stock Appreciation Right
5.00
2024-01-21
Common Stock
6486
D
The shares subject to the option shall become vested and exercisable according to the following schedule: 25% of the shares subject to the option shall vest on the first anniversary of the grant date, and the remaining shares shall vest in equal monthly installments over the next 36 months.
The shares subject to the option shall become vested and exercisable according to the following schedule: 25% of the shares subject to the option shall vest on July 22, 2017, and the remaining shares shall vest in equal monthly installments over the next 36 months.
This incentive award (the "Award") was granted under the Issuer's 2013 Equity Incentive Plan and can be settled in cash or shares of the Issuer's common stock, at the sole discretion of the Issuer. The shares subject to the Award shall vest in 48 equal monthly installments from the grant date.
/s/ Daniel Menold
2017-05-05
EX-24.3_721549
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
Know all by these presents, that the undersigned hereby constitutes and appoints
each of SUJAL SHAH, CHARLES MCWHERTER, MATTHEW HEMINGTON AND BRETT WHITE,
signing individually, the undersigned's true and lawful attorneys-in-fact and
agents to:
(1) execute for and on behalf of the undersigned, an officer, director or holder
of 10% of more of a registered class of securities of CymaBay Therapeutics, Inc.
(the "Company"), Forms 3, 4 and 5 in accordance with Section 16(a) of the
Securities Exchange Act of 1934, as amended (the "Exchange Act") and the rules
thereunder;
(2) do and perform any and all acts for and on behalf of the undersigned that
may be necessary or desirable to complete and execute such Form 3, 4 or 5,
complete and execute any amendment or amendments thereto, and timely file such
forms or amendments with the United States Securities and Exchange Commission
and any stock exchange or similar authority; and
(3) take any other action of any nature whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit, in
the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Exchange Act.
This Power of Attorney shall remain in full force and effect until the earliest
to occur of (a) the undersigned is no longer required to file Forms 3, 4 and 5
with respect to the undersigned's holdings of and transactions in securities
issued by the Company, (b) revocation by the undersigned in a signed writing
delivered to the foregoing attorneys-in-fact, or (c) as to any attorney-in-fact
individually, until such attorney-in-fact shall no longer be employed by the
Company or Cooley LLP, as the case may be.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 2nd day of May, 2017.
/s/ Daniel Menold
Daniel Menold